NeoGenomics Future Growth
Future criteria checks 1/6
NeoGenomics is forecast to grow earnings and revenue by 31.9% and 9.7% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 4.9% in 3 years.
Key information
31.9%
Earnings growth rate
33.7%
EPS growth rate
Healthcare earnings growth | 19.4% |
Revenue growth rate | 9.7% |
Future return on equity | 4.9% |
Analyst coverage | Good |
Last updated | 05 Aug 2024 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With NeoGenomics, Inc.'s (NASDAQ:NEO) Prospects As Shares Rocket 29%
Aug 01Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Jul 15Investors Interested In NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues
Mar 30Investor Optimism Abounds NeoGenomics, Inc. (NASDAQ:NEO) But Growth Is Lacking
Dec 26Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Aug 23Risks To Shareholder Returns Are Elevated At These Prices For NeoGenomics, Inc. (NASDAQ:NEO)
Jul 16NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt
Apr 18We Think NeoGenomics (NASDAQ:NEO) Has A Fair Chunk Of Debt
Jan 10NeoGenomics: Market Punishment Continues, But Looks Justified
Sep 30NeoGenomics grants CEO restricted shares, stock options
Aug 17Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt
Aug 10NeoGenomics rises ~14% on strong Q2 result
Aug 09NeoGenomics gets new CEO
Jul 21NeoGenomics: Refrain From Portfolio Allocation, Negligible Upside Potential
Jun 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Apr 22Neogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral
Apr 08Why NeoGenomics, Inc. (NASDAQ:NEO) Could Be Worth Watching
Feb 11Is NeoGenomics (NASDAQ:NEO) Weighed On By Its Debt Load?
Jan 07NeoGenomics: Gambling On Growth
Dec 16NeoGenomics: Profitability Headwinds Compress Valuation, Shares
Sep 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Sep 24Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 795 | -34 | 2 | N/A | 9 |
12/31/2025 | 725 | -52 | -33 | 52 | 13 |
12/31/2024 | 662 | -83 | -59 | -6 | 13 |
6/30/2024 | 628 | -79 | -30 | 0 | N/A |
3/31/2024 | 611 | -84 | -40 | -15 | N/A |
12/31/2023 | 592 | -88 | -31 | -2 | N/A |
9/30/2023 | 575 | -96 | -50 | -23 | N/A |
6/30/2023 | 552 | -115 | -64 | -34 | N/A |
3/31/2023 | 530 | -126 | -82 | -50 | N/A |
12/31/2022 | 510 | -144 | -97 | -66 | N/A |
9/30/2022 | 497 | -163 | -120 | -82 | N/A |
6/30/2022 | 489 | -147 | -119 | -74 | N/A |
3/31/2022 | 486 | -36 | -115 | -58 | N/A |
12/31/2021 | 484 | -8 | -91 | -27 | N/A |
9/30/2021 | 485 | 49 | -65 | -1 | N/A |
6/30/2021 | 489 | 72 | -49 | 7 | N/A |
3/31/2021 | 454 | -11 | -30 | 11 | N/A |
12/31/2020 | 444 | 4 | -28 | 1 | N/A |
9/30/2020 | 425 | -5 | -25 | -1 | N/A |
6/30/2020 | 405 | -5 | -6 | 17 | N/A |
3/31/2020 | 419 | 3 | -11 | 10 | N/A |
12/31/2019 | 409 | 8 | 3 | 23 | N/A |
9/30/2019 | 378 | 2 | 18 | 35 | N/A |
6/30/2019 | 343 | 2 | 13 | 25 | N/A |
3/31/2019 | 309 | 6 | 24 | 37 | N/A |
12/31/2018 | 277 | 6 | 30 | 45 | N/A |
9/30/2018 | 262 | 8 | 20 | 35 | N/A |
6/30/2018 | 252 | -1 | 19 | 34 | N/A |
3/31/2018 | 246 | -9 | N/A | 34 | N/A |
12/31/2017 | 240 | -11 | N/A | 18 | N/A |
9/30/2017 | 239 | -27 | N/A | 12 | N/A |
6/30/2017 | 241 | -26 | N/A | 14 | N/A |
3/31/2017 | 242 | -29 | N/A | 13 | N/A |
12/31/2016 | 232 | -31 | N/A | 21 | N/A |
9/30/2016 | 211 | -18 | N/A | 24 | N/A |
6/30/2016 | 175 | -12 | N/A | 17 | N/A |
3/31/2016 | 136 | -7 | N/A | 14 | N/A |
12/31/2015 | 100 | -3 | N/A | 6 | N/A |
9/30/2015 | 98 | 0 | N/A | 5 | N/A |
6/30/2015 | 96 | 0 | N/A | 6 | N/A |
3/31/2015 | 92 | 0 | N/A | 8 | N/A |
12/31/2014 | 87 | 1 | N/A | 9 | N/A |
9/30/2014 | 80 | 1 | N/A | 8 | N/A |
6/30/2014 | 74 | 2 | N/A | 7 | N/A |
3/31/2014 | 69 | 2 | N/A | 5 | N/A |
12/31/2013 | 66 | 2 | N/A | 2 | N/A |
9/30/2013 | 63 | 1 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NEO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NEO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NEO's revenue (9.7% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: NEO's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NEO's Return on Equity is forecast to be low in 3 years time (4.9%).